Table 2.

Associations of ARHGDIA expression with the clinical features of glioma patients (n = 73)

Clinicopathologic variables	ARHGDIA expression		Average score	Expression level	p value
	Negative (n = 24)	Positive (n = 49)
Gender
Male	9	30	1.42 ± 0.10	+	0.081
Female	15	19	1.35 ± 0.15	+
Age, (years)
≤56	10	31	1.46 ± 0.11	+	0.131
>56	14	18	1.28 ± 0.11	+
TNM stage
I–II	11	9	1.67 ± 0.23	+	0.048
III–IV	12	33	1.27 ± 0.08	+
Unknown	1	7

+: ARHGDIA staining was scored 1–2 (weak expression)